Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Inoveon
company
About
Inoveon Corporation is a medical services company that delivers solutions to detect, and stage and monitor diseases affecting the eye,
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $17.50M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 1999
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Inoveon Corporation is a medical services company that delivers solutions to detect, and stage and monitor diseases affecting the eye, diabetic retinopathy, macular degeneration, and glaucoma. The company offers iScan that detects and evaluates diabetic retinopathy and macular edema; INOVEON System, which works with physician groups to improve DR compliance rates. Inoveon Corporation was founded in 1997 and is based in Oklahoma City, Oklahoma. As of November 18, 2010, Inoveon Corporation operates as a subsidiary of Ifa Systems Ag.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17.50M
Inoveon has raised a total of
$17.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2002 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2002 | Series B | $17.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Inoveon is funded by 2 investors.
Chisholm Private Capital Partners
and Massey Burch Capital Corporation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Chisholm Private Capital Partners
|
— | Series B |
Massey Burch Capital Corporation
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
